東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Nanoparticles in the management of a...

Mehta, Sourabh.

FindBook

Google Book

Amazon

博客來

Nanoparticles in the management of atherosclerosis = a machine-generated literature overview /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nanoparticles in the management of atherosclerosis/ edited by Sourabh Mehta.
其他題名:	a machine-generated literature overview /
其他作者:	Mehta, Sourabh.
出版者:	Cham :Springer Nature Switzerland : : 2025.,
面頁冊數:	xvii, 419 p. :ill. (some col.), digital ;24 cm.
內容註:	Introduction to atherosclerosis -- Introduction to nanoparticles, synthesis characterization and clinical status -- Nanoparticles used in diagnosis of atherosclerosis -- Theranostic-Nanoparticles used for atherosclerosis.
Contained By:	Springer Nature eBook
標題:	Atherosclerosis - Treatment. -
電子資源:	https://doi.org/10.1007/978-3-031-46752-3
ISBN:	9783031467523

Nanoparticles in the management of atherosclerosis = a machine-generated literature overview /
Nanoparticles in the management of atherosclerosisa machine-generated literature overview /[electronic resource] :edited by Sourabh Mehta. - Cham :Springer Nature Switzerland :2025. - xvii, 419 p. :ill. (some col.), digital ;24 cm.

Introduction to atherosclerosis -- Introduction to nanoparticles, synthesis characterization and clinical status -- Nanoparticles used in diagnosis of atherosclerosis -- Theranostic-Nanoparticles used for atherosclerosis.

The book's primary objective is to introduce the pathology and physiology atherosclerosis in brief, and its diagnosis and treatment. Atherosclerosis is an inflammatory disease of the arterial wall. An advanced understanding of atherosclerosis shows that it leads to myocardial infarction and other cardiovascular diseases, taking 17 million people every year worldwide. The literature suggests that atherosclerosis is an ancient disease and is still a long-standing health problem globally. Hence early diagnosis and treatment of atherosclerosis are crucial to solving long-standing health issues. This book provides a systemic summary of recent literature focusing on disease pathology, advancement in diagnosis and therapies. Recently, nanoparticles performing dual roles as diagnostic and therapeutic agents have been keenly interested. However, the nanoparticle has yet to reach the clinic. Understanding the role of biomaterials in formulations and existing strategies is critical when developing novel formulations and working on translation to clinical settings. The book provides a systematic biomaterial-based summary of the literature, methods used to formulate nanoparticles, and their scale-up potential. Another key objective of the book is to motivate the reader to conduct research on theranostic nanoparticles to treat atherosclerosis and put us one step closer to solving a long-standing health problem-atherosclerosis. The auto-summaries have been generated by a recursive clustering algorithm via the Dimensions Auto-summarizer by Digital Science handled by Subject Matter Experts and the external editor. The editor of this book selected which SN content should be auto-summarized and decided its order of appearance. Please be aware that the auto-summaries consist of original sentences, but are not representative of its original paper, since we do not show the full length of the publication. Please note that only published SN content is represented here, and that machine-generated books are still at an experimental stage.

ISBN: 9783031467523

Standard No.: 10.1007/978-3-031-46752-3doiSubjects--Topical Terms:

1619261
Atherosclerosis
--Treatment.

LC Class. No.: RC692

Dewey Class. No.: 616.136

Nanoparticles in the management of atherosclerosis = a machine-generated literature overview /
LDR:03356nmm a2200349 a 4500 001 2408440
003 DE-He213
005 20250129204218.0
006 m d
007 cr nn 008maaau
008 260204s2025 sz s 0 eng d
020 $a 9783031467523 $q (electronic bk.)
020 $a 9783031467516 $q (paper)
024 7 $a 10.1007/978-3-031-46752-3 $2 doi
035 $a 978-3-031-46752-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC692
072 7 $a TBN $2 bicssc
072 7 $a TCB $2 bicssc
072 7 $a TEC027000 $2 bisacsh
072 7 $a TBN $2 thema
072 7 $a TCB $2 thema
082 0 4 $a 616.136 $2 23
090 $a RC692 $b .N186 2025
245 0 0 $a Nanoparticles in the management of atherosclerosis $h [electronic resource] : $b a machine-generated literature overview / $c edited by Sourabh Mehta.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2025.
300 $a xvii, 419 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Introduction to atherosclerosis -- Introduction to nanoparticles, synthesis characterization and clinical status -- Nanoparticles used in diagnosis of atherosclerosis -- Theranostic-Nanoparticles used for atherosclerosis.
520 $a The book's primary objective is to introduce the pathology and physiology atherosclerosis in brief, and its diagnosis and treatment. Atherosclerosis is an inflammatory disease of the arterial wall. An advanced understanding of atherosclerosis shows that it leads to myocardial infarction and other cardiovascular diseases, taking 17 million people every year worldwide. The literature suggests that atherosclerosis is an ancient disease and is still a long-standing health problem globally. Hence early diagnosis and treatment of atherosclerosis are crucial to solving long-standing health issues. This book provides a systemic summary of recent literature focusing on disease pathology, advancement in diagnosis and therapies. Recently, nanoparticles performing dual roles as diagnostic and therapeutic agents have been keenly interested. However, the nanoparticle has yet to reach the clinic. Understanding the role of biomaterials in formulations and existing strategies is critical when developing novel formulations and working on translation to clinical settings. The book provides a systematic biomaterial-based summary of the literature, methods used to formulate nanoparticles, and their scale-up potential. Another key objective of the book is to motivate the reader to conduct research on theranostic nanoparticles to treat atherosclerosis and put us one step closer to solving a long-standing health problem-atherosclerosis. The auto-summaries have been generated by a recursive clustering algorithm via the Dimensions Auto-summarizer by Digital Science handled by Subject Matter Experts and the external editor. The editor of this book selected which SN content should be auto-summarized and decided its order of appearance. Please be aware that the auto-summaries consist of original sentences, but are not representative of its original paper, since we do not show the full length of the publication. Please note that only published SN content is represented here, and that machine-generated books are still at an experimental stage.
650 0 $a Atherosclerosis $x Treatment. $3 1619261
650 0 $a Nanoparticles $x Therapeutic use. $3 2017631
650 0 $a Nanomedicine. $3 900993
650 0 $a Nanobiotechnology. $3 2059335
650 0 $a Cardiovascular system. $3 783051
650 0 $a Physiology. $3 518431
650 0 $a Cardiology. $3 861477
650 0 $a Nanotechnology. $3 526235
650 0 $a Molecular biology. $3 517296
650 2 4 $a Cardiovascular Physiology. $3 773622
650 2 4 $a Molecular Biology. $3 600567
700 1 $a Mehta, Sourabh. $3 3780940
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-46752-3
950 $a Chemistry and Materials Science (SpringerNature-11644)